A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
about
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesRadiotherapy and "new" drugs-new side effects?EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published dataWhole brain radiotherapy with radiosensitizer for brain metastasesRationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistanceA nomogram for individualized estimation of survival among patients with brain metastasisWhole brain radiotherapy for brain metastasis.SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration.A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.Acquirement of DNA copy number variations in non-small cell lung cancer metastasis to the brain.Molecular targets for tumor radiosensitization.Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer.Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancerNeuropsychological testing and biomarkers in the management of brain metastasesRadiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.Whole-brain radiation therapy in breast cancer patients with brain metastases.Therapy and prophylaxis of brain metastases.Recent advances in anti-angiogenic therapy of cancerManagement of brain metastasis: past lessons, modern management, and future considerations.Using NF-κB as a molecular target for theranostics in radiation oncology research.The emerging quest for the optimal angiostatic combination therapy.Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.Updates in the management of brain metastases.Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.Comparison of futility monitoring guidelines using completed phase III oncology trials.The role of radiation therapy in the management of metastatic melanoma in the brain.A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer.Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.Gamma Knife radiosurgery as a primary treatment option for solitary brain metastases from ovarian carcinoma.
P2860
Q24200466-B8C3C96E-EA93-4454-8DC4-D106B49E9C29Q26861498-A1CE668F-4C7B-47AC-B6F3-F0000F5D56E9Q30871237-605C089C-008F-47B6-A4DD-072150D4FDACQ33397865-C61A9324-E7CA-4FA5-9F21-133F055CB346Q33755725-8119D2E9-71B9-4B58-AD15-247162BE4A39Q33777436-65941CBE-30DF-4B76-9778-7DC09A893CEEQ33820264-42F9B512-0273-406F-B477-AF907C6B3B61Q34250819-D720C2E2-0540-4A7F-AE03-7BC4F33F9035Q34347439-C3343AEC-4946-4D1C-81C1-9BE14FAF4928Q35042352-11B45DE1-D765-4B04-8A3A-8373A33C27F2Q35207344-F36253BF-B1D7-4E14-A7F3-1ABDFF191AD7Q35742324-DEFD0E8D-BE2B-4B08-AF68-E6BA8A8F4A7EQ36041731-A936A5C4-133D-422F-9B43-8CD3AD2E5C51Q36126009-EA5B4C77-CF24-4863-8BF7-BC4E3BBAA7C8Q36402837-4DEEE80F-9499-4198-A595-E622ED36A6FDQ36625206-1863DF9B-D14C-45CA-9949-E17087FAA2C9Q36915247-3A9E288D-D354-4754-AC8D-114196FF0A36Q37256355-4B6EA768-3B27-4E79-88A1-309B28AE71AFQ37772075-14C3CD3F-F4E4-43AE-A778-7FBD8B924388Q37809862-53D97327-6EB3-4776-A4E2-16B26478AFF7Q37852512-382F577D-71E8-4131-8C56-2A4C3A41C4CAQ37954518-6C518AE0-31B6-48EE-A98F-F8C64FB53248Q37988573-2BDFD09B-CED5-4710-BF9E-9FFEED2C203FQ38268453-059C2A2C-9DC3-47D9-85C8-B9593DBEF6B1Q38414698-5C964D9B-4D7C-436A-8D8D-F9C724EBEC6FQ38548397-799EE772-9729-42E8-B2AB-656871FF00A4Q38763111-CE960AC0-FEC1-4917-8E63-F870F91185D7Q38887451-ECDC6021-C2FD-4BA6-A3CC-E367522AFFDDQ38918333-E655DA07-B7B4-4365-90A8-06B16505B818Q38973621-8C8D9AA8-CF27-4B62-99E3-ABA57256F8B7Q39427133-910FCE5E-FE4B-4847-91E2-6D77CB3FB658Q42535832-5D9CCB01-6317-42B4-AA1A-4F5E0146D992Q43121438-C1922FEA-4F22-4BBB-BB61-16D500B46217Q47142558-C1619D42-AFF8-4EA2-AAD9-05117445458CQ48092592-BFC52DE0-07C8-4D92-A1ED-41A8C439EA6AQ48409755-B1F247EE-7C45-4266-ADB5-39229092817BQ48610540-37C78176-F17C-4A29-BCAA-D8091B9946CB
P2860
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A phase III study of conventio ...... brain metastases (RTOG 0118).
@ast
A phase III study of conventio ...... brain metastases (RTOG 0118).
@en
A phase III study of conventio ...... for multiple brain metastases
@nl
type
label
A phase III study of conventio ...... brain metastases (RTOG 0118).
@ast
A phase III study of conventio ...... brain metastases (RTOG 0118).
@en
A phase III study of conventio ...... for multiple brain metastases
@nl
prefLabel
A phase III study of conventio ...... brain metastases (RTOG 0118).
@ast
A phase III study of conventio ...... brain metastases (RTOG 0118).
@en
A phase III study of conventio ...... for multiple brain metastases
@nl
P2093
P1476
A phase III study of conventio ...... e brain metastases (RTOG 0118)
@en
P2093
Al W K Yung
Arnab Chakravarti
Benjamin Movsas
Brian Berkey
David G Brachman
H Ian Robins
Jonathan P S Knisely
Walter J Curran
P356
10.1016/J.IJROBP.2007.09.016
P407
P577
2007-12-31T00:00:00Z